ReleaseWire Connect

An investigation on behalf of investors of Verisk Analytics, Inc. (NASDAQ:VRSK) shares over potential securities laws violations by Verisk Analytics and certain of its directors and officers in connection certain financial statements was announced.

An investor in shares of Facebook Inc (NASDAQ:FB) filed a lawsuit against directors of Facebook Inc in connection with the compensation of certain nonexecutive directors.

An investigation on behalf of investors of Pacific Coast Oil Trust (NYSE:ROYT) shares over potential securities laws violations by Pacific Coast Oil Trust and certain of its directors and officers in connection certain financial statements was announced.

An investigation on behalf of investors, who currently hold shares of OpenTable Inc (NASDAQ:OPEN) shares, was announced concerning whether the takeover of OpenTable Inc. by The Priceline Group Inc for $103 per shareis unfair to NASDAQ:OPEN stockholders.

An investor, who currently holds shares of Protective Life Corp. (NYSE:PL) filed a lawsuit in effort to halt the takeover of Protective Life Corp. by Dai-ichi Life Insurance Company.

An investor, who purchased shares of Ocean Power Technologies Inc (NASDAQ:OPTT), filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Ocean Power Technologies Inc in connection with certain allegedly false and misleading statements made between January 14, 2014 and June 9, 2014.

An investigation on behalf of investors of Bancorp Inc (NASDAQ:TBBK) shares over potential securities laws violations by Bancorp and certain of its directors and officers in connection certain financial statements was announced.

An investigation for long-term investors in NYSE:WTW shares over potential breaches of fiduciary duties by certain Weight Watchers directors and officers was announced.

An investigation on behalf of investors, who currently hold shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX), was announced concerning whether the takeover of Idenix Pharmaceuticals Inc . by Merck for $24.50 per shares is unfair to NASDAQ:IDIX stockholders.

An investor who currently holds NYSE:ESI shares filed a lawsuit against directors of ITT Educational Services, Inc. (NYSE:ESI) over alleged breaches of fiduciary duties.